Syndax Pharmaceuticals

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell SNDX and other ETFs, options, and stocks.

About SNDX

Syndax Pharmaceuticals, Inc. engages in the development of cancer therapies. Its products include SyndAccess, Revuforj, Niktimvo, and IncyteCARES. 

CEO
Michael A. Metzger
CEOMichael A. Metzger
Employees
270
Employees270
Headquarters
New York, New York
HeadquartersNew York, New York
Founded
2005
Founded2005
Employees
270
Employees270

SNDX Key Statistics

Market cap
1.76B
Market cap1.76B
Price-Earnings ratio
-5.60
Price-Earnings ratio-5.60
Dividend yield
Dividend yield
Average volume
1.17M
Average volume1.17M
High today
$21.00
High today$21.00
Low today
$19.90
Low today$19.90
Open price
$20.70
Open price$20.70
Volume
1.08M
Volume1.08M
52 Week high
$22.73
52 Week high$22.73
52 Week low
$8.58
52 Week low$8.58

Stock Snapshot

The current Syndax Pharmaceuticals(SNDX) stock price is $19.90, with a market capitalization of 1.76B. The stock trades at a price-to-earnings (P/E) ratio of -5.60.

As of 2026-01-24, Syndax Pharmaceuticals(SNDX) stock has fluctuated between $19.90 and $21.00. The current price stands at $19.90, placing the stock 0.0% above today's low and -5.2% off the high.

The Syndax Pharmaceuticals(SNDX)'s current trading volume is 1.08M, compared to an average daily volume of 1.17M.

In the last year, Syndax Pharmaceuticals(SNDX) shares hit a 52-week high of $22.73 and a 52-week low of $8.58.

In the last year, Syndax Pharmaceuticals(SNDX) shares hit a 52-week high of $22.73 and a 52-week low of $8.58.

SNDX News

Simply Wall St 7d
Expanded Global Access To Revuforj Could Be A Game Changer For Syndax Pharmaceuticals

Earlier this month, the World Orphan Drug Alliance and Syndax Pharmaceuticals announced a collaboration to expand global access to Syndax’s first-in-class menin...

Expanded Global Access To Revuforj Could Be A Game Changer For Syndax Pharmaceuticals

Analyst ratings

100%

of 14 ratings
Buy
100%
Hold
0%
Sell
0%

People also own

Based on the portfolios of people who own SNDX. This list is generated using Robinhood data, and it’s not a recommendation.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.